Neurology · Psychiatry · 7 h ago
Single-cell analysis maps Alzheimer’s phenotypes to brain cell subpopulations
An observational computational study identified approximately 1.5 million phenotype-associated brain cells from 584 donors with Alzheimer’s-related phenotypes. The PASCode framework linked cell subpopulations and gene-expression patterns to pathology, cognition and depression, with findings validated in external datasets.
- PASCode identified approximately 1.5 million phenotype-associated cells from 584 donors.
- Cellular patterns differed across pathology, cognition and depression phenotypes.
- External datasets supported findings; clinical utility remains unestablished.
Researchers developed an artificial intelligence–based framework to investigate cellular correlates of the diverse clinical phenotypes of Alzheimer’s disease (AD). The study used the PsychAD single-nucleus RNA sequencing resource, comprising more than 6 million nuclei from the prefrontal cortex of over 1,000 brains. The Phenotype Associated Single Cell encoder (PASCode) combines statistical methods in a graph neural model to score associations between individual cells and phenotypes.
The analysis identified approximately 1.5 million phenotype-associated cells from 584 donors with AD-related phenotypes. Comparisons across 27 brain cell subclasses prioritized microglial subpopulations associated with AD pathology and reactive astrocyte subtypes potentially linked to cognitive resilience. Cognitively impaired AD donors showed patterns consistent with increased excitatory/inhibitory imbalance and mitochondrial dysfunction. Astrocytes associated with both AD and depression displayed gene-expression patterns involving inflammation and endoplasmic reticulum stress pathways.
The authors validated findings in external population-scale datasets covering AD and major depressive disorder. They also produced an AD phenotypic single-cell atlas and released PASCode as an open-source tool with pretrained models and a web application. These results may help prioritize diagnostic and therapeutic research targets, but the observational associations do not establish causality or demonstrate clinical utility. The supplied abstract does not report effect sizes or quantitative validation performance.
Is this summary clinically accurate?
Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.
Sign in to rate this summary →Source
Nature Medicine: AI-based characterization of Alzheimer’s disease phenotypes from population-scale single-cell data ↗This is an automated AI-condensed summary that has not yet been reviewed by an editor. Always consult the full item at the original source.
